| Turcja | Austria | Hiszpania | |
| Leczenie nadciśnienia płucnego komórkami macierzystymi | od $12,000 | od $55,000 | od $25,000 |
Turkey is a hub for pulmonary hypertension treatment, with Memorial Şişli Hospital, Memorial Ataşehir Hospital, and Anadolu Medical Center leading. These JCI-accredited facilities ensure quality and safety. Memorial Şişli Hospital, the first in Turkey with JCI accreditation, offers multidisciplinary treatment approaches.
Success rates for pulmonary hypertension treatments in Turkey are promising. Innovative procedures like pulmonary endarterectomy, balloon pulmonary angioplasty, and lung transplantation improve outcomes. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, provides American standards. Recent advancements include targeted therapies and gene therapy, with sildenafil showing efficacy in a study.
Germany excels in Pulmonary hypertension treatment, with top centers like the Düsseldorf Clinics Association, Asklepios Hospital Barmbek, and Nordrhein-Westfalen Clinic Complex. The Cooperation for Transparency and Quality in the Health Service accredits these clinics. Düsseldorf Clinics Association treats over 200,000 patients annually, with expertise in cardiology and pulmonology. Asklepios Hospital Barmbek, part of Germany's largest hospital network, serves around 80,000 patients yearly, specializing in pulmonology.
The Nordrhein-Westfalen Clinic Complex, featuring Germany's largest Heart Center, treats over 145,000 patients annually. Recent advancements include balloon pulmonary angioplasty, targeted molecular therapies, and catheter-based interventions. For detailed statistics, refer to the latest data on Pulmonary hypertension treatment.
Spain leads in Pulmonary hypertension treatment with top clinics like Centro Médico Teknon, SJD Barcelona Children’s Hospital, and HM Hospitales. Accredited by the Joint Commission International, they offer procedures such as balloon pulmonary angioplasty, pulmonary endarterectomy, targeted medical therapy, and lung transplantation.
Spain's Pulmonary hypertension treatment success is notable, with survival rates around 90%. Centro Médico Teknon, SJD Barcelona Children’s Hospital, and HM Hospitales contribute significantly to these outcomes through advanced diagnostics and personalized care.
Israel excels in Pulmonary hypertension treatment with top centers like Sourasky Medical Center (Ichilov), Assuta Medical Center, and Hadassah Medical Center. These are accredited by Joint Commission International, ensuring quality and safety. Sourasky treats 400,000 patients annually, focusing on oncology and cardiology. Assuta, Israel's largest private clinic, specializes in cardiology with VenaSeal and Cryo. Hadassah is renowned for its comprehensive care.
Israel's Pulmonary hypertension treatment success is high, using procedures like balloon pulmonary angioplasty, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs. The survival rate is promising, supported by continuous research and technology advancements. For detailed statistics, refer to the National Comprehensive Cancer Network.